PTC Therapeutics Inc. buy JPMorgan Chase & Co.
Start price
21.05.24
/
50%
€35.00
Target price
21.05.25
€48.82
Performance (%)
-2.86%
Price
13.06.24
€34.00
Summary
This prediction is currently active. With a performance of -2.86%, the BUY prediction by JPMorgan_Chase___Co_ is trending in the wrong direction. This prediction currently runs until 21.05.25. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
PTC Therapeutics Inc. | 2.410% |
iShares Core DAX® | -2.926% |
iShares Nasdaq 100 | 4.462% |
iShares Nikkei 225® | 0.306% |
iShares S&P 500 | 2.488% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread PTC Therapeutics Inc. diskutieren
PTC Therapeutics, Inc. (NASDAQ: PTCT) had its price target raised by analysts at JPMorgan Chase & Co. from $43.00 to $53.00. They now have an "overweight" rating on the stock.
Ratings data for PTCT provided by MarketBeat